VCM
DNMR

Versant Capital Management’s Danimer Scientific, Inc. DNMR Stock Holding History

Versant Capital Management’s Portfolio DNMR Stock Details DNMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2
Closed – – 1705
2022
Q2 		$0 Buy
+2
New +$363 ﹤0.01% 1687

Other funds holding DNMR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
TA
Teramo Advisors Naples, Florida $529M AUM 20.59% 1-Year Est. Return

Versant Capital Management's DNMR Position: Q3 2022 in Review

Versant Capital Management sold out of Danimer Scientific, Inc. (DNMR) in Q3 2022, closing a stake of 2 shares.

Versant Capital Management first reported a position in DNMR in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 186 funds tracked by Wall St. Rank hold DNMR as of Q3 2022.

  • Versant Capital Management reported no remaining Danimer Scientific, Inc. position as of Q3 2022 after selling out during the quarter.
  • Versant Capital Management sold 2 Danimer Scientific, Inc. shares in Q3 2022.
  • Versant Capital Management first reported a position in Danimer Scientific, Inc. in Q2 2022 and held it in 1 quarter.
  • Versant Capital Management's Danimer Scientific, Inc. position peaked at $0 in Q2 2022.
  • 186 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q3 2022.

Based on Versant Capital Management's 13F filing for Q3 2022, filed 30 Dec 2022.